PRGO.TA - Perrigo Company plc

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
17,010.00
+290.00 (+1.73%)
At close: 5:24PM IDT
Stock chart is not supported by your current browser
Previous Close16,720.00
Open16,720.00
Bid16,880.00 x 7100
Ask16,900.00 x 29700
Day's Range16,680.00 - 17,070.00
52 Week Range13,730.00 - 28,300.00
Volume78,058
Avg. Volume133,110
Market Cap22.919B
Beta (3Y Monthly)1.40
PE Ratio (TTM)26,619.72
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield2.96 (1.74%)
Ex-Dividend Date2019-08-29
1y Target EstN/A
  • Barrons.com

    The 6 Worst Health-Care Stocks So Far This Month

    For health care investors this August, things could have been worse. But the past few weeks have been downright disastrous for some stocks.

  • PetIQ, Inc. (PETQ) Q2 2019 Earnings Call Transcript
    Motley Fool

    PetIQ, Inc. (PETQ) Q2 2019 Earnings Call Transcript

    PETQ earnings call for the period ending June, 30, 2019.

  • Perrigo (PRGO) Q2 2019 Earnings Call Transcript
    Motley Fool

    Perrigo (PRGO) Q2 2019 Earnings Call Transcript

    PRGO earnings call for the period ending June 30, 2019.

  • TheStreet.com

    Perrigo Beats Second-Quarter Estimates but Stock Tumbles

    Perrigo is falling despite beating Wall Street's second-quarter earnings and revenue expectations.

  • Benzinga

    Perrigo Reports Q2 Earnings, Reaffirms Guidance

    Perrigo Co (NYSE: PRGO) reported second-quarter earnings of 86 cents per share, which beat the analyst consensus estimate of 79 cents by 8.86%. The company reported quarterly sales of $1.127 billion, which missed the analyst consensus estimate of $1.13 billion by 0.27%.

  • MarketWatch

    Perrigo's stock surges after profit and revenue decline less than expected, outlook affirmed

    Shares of Perrigo Co. surged 6.0% in premarket trading Thursday, after the over-the-counter health and wellness products company reported second-quarter profit and revenue that beat expectations, and affirmed its full-year outlook. Net income fell to $9 million, or 7 cents a share, from $36 million, or 26 cents a share, in the year-ago period. Excluding non-recurring items, adjusted EPS fell to 86 cents from $1.22, above the FactSet consensus of 79 cents. Sales declined 3.1% to $1.15 billion but topped the FactSet consensus of $1.13 billion, as consumer self-care America sales fell 2.5%, consumer self-care international sales declined 8.5% and prescription pharmaceuticals sales rose 3.4%. The company affirmed its 2019 adjusted EPS outlook of $3.75 to $4.05. The stock has run up 30.3% year to date through Wednesday, while the S&P 500 has gained 15.0%.

  • Benzinga

    Q2 Earnings Preview For Perrigo

    Perrigo Co (NYSE: PRGO ) releases its next round of earnings this Thursday, August 8. Get the latest predictions in Benzinga's essential guide to the company's Q2 earnings report. Earnings and Revenue ...

  • Benzinga

    Perrigo Adjusts Guidance After Acquiring Ranir Global For $750M

    Perrigo Company (NYSE: PRGO ) has acquired Ranir Global Holdings, a supplier of oral self-care products for $750 million in cash. Perrigo also adjusted its FY2019 earnings guidance, from $3.75-$4.05 including ...

  • Reuters

    US STOCKS-Wall St falls as weak economic data triggers growth worries

    U.S. stocks fell on Wednesday, as a clutch of weak economic data from the United States and China sparked worries of slowing global growth against the backdrop of a bitter trade dispute that has roiled financial markets. Domestic data showed retail sales unexpectedly fell in April as households cut back on purchases of motor vehicles and a range of other goods, and another report showed declining output of cars and machinery led to a surprise fall in U.S. factory production for April. Meanwhile data from China also showed surprisingly weak growth in retail sales and industrial output for April, adding pressure on the country to roll out more stimulus.

  • Reuters

    US STOCKS-Wall St set to open lower after weak retail sales data

    Wall Street was set to open lower on Wednesday, as a surprise fall in domestic retail sales and underwhelming data from China raised growth concerns, while investors waited for more developments on the U.S.-China trade dispute. Government data showed U.S. retail sales unexpectedly fell in April as motor vehicle purchases slumped, while data from China also showed surprisingly weak growth in retail sales and industrial output for April, adding pressure on Beijing to roll out more stimulus. "The U.S. retail sales report is clearly disappointing.

  • TheStreet.com

    Perrigo Buys Oral Care Company Ranir for $750 Million as Part of New Strategy

    was gaining more than 5% Thursday after announcing the all-cash acquisition of privately-held Ranir Global Holdings in a deal valued at $750 million. Ranir is the largest private label oral care company in the world, according to Perrigo, with a portfolio of more than 300 oral care products including toothbrush heads and whitening strips. "The addition of Ranir to the Perrigo family illustrates a key component of our new strategy, accelerating growth by pursuing adjacent self-care categories.

  • PetIQ, Inc. (PETQ) Q1 2019 Earnings Call Transcript
    Motley Fool

    PetIQ, Inc. (PETQ) Q1 2019 Earnings Call Transcript

    PETQ earnings call for the period ending March 31, 2019.

  • Associated Press

    Perrigo: 1Q Earnings Snapshot

    The Dublin-based company said it had net income of 47 cents per share. Earnings, adjusted for one-time gains and costs, came to $1.07 per share. The results beat Wall Street expectations. The average estimate ...

  • TheStreet.com

    IRS Has Wrong Prescription for Perrigo

    tumbled 7.3% to $47.67 Tuesday after the pharmaceutical company said it had received an $843 million bill from the Internal Revenue Service. The Dublin-based company said in a filing that it had gotten a revised Notice of Proposed Adjustment from the IRS examination team auditing Athena Neurosciences Inc. for the years ended Dec. 31, 2011 - 2013. Athena was acquired as a U.S. subsidiary by Elan Corp. in 1996 and Perrigo acquired Elan through a December 2013 business combination between Perrigo's predecessor and Elan.

  • Perrigo Company PLC (PRGO) Q4 2018 Earnings Conference Call Transcript
    Motley Fool

    Perrigo Company PLC (PRGO) Q4 2018 Earnings Conference Call Transcript

    PRGO earnings call for the period ending December 31, 2018.

  • Why Perrigo Stock Fell 38% in December
    Motley Fool

    Why Perrigo Stock Fell 38% in December

    Prospects of a huge tax bill spooked investors last month.

  • See what the IHS Markit Score report has to say about Perrigo Company PLC.
    Markit

    See what the IHS Markit Score report has to say about Perrigo Company PLC.

    Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on December 27. Index (PMI) data, output in the Healthcare sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way.

  • CNBC

    Stocks making the biggest moves premarket: INTC, WMT, TGT, M, MAR, EXPE & more

    Intel received a $185 million grant from the Israeli government in return for a $5 billion expansion of its chip making operations in Israel. Walmart WMT , Target TGT , Macy's M – These and other retail stocks are on watch today, following holiday shopping season numbers that were the best in six years. The Wall Street Journal reports that this negotiation is seen as key in the industry, with the world's largest hotel company having more clout than ever following its takeover of Starwood two years ago.

  • Associated Press

    Alphabet, Northrop Grumman and Perrigo skid while Nike rises

    Stocks that moved substantially or traded heavily Friday: Nike Inc., up $4.84 to $72.37 The athletic gear giant reported strong second-quarter results. Northrop Grumman Corp., down $8.38 to $235.24 Defense ...